Nventa's CEO to Present at the BIOCOM Investor Conference 2007

SAN DIEGO, Oct. 30 Nventa Biopharmaceuticals Corporation(TSX: NVN) announced today that Gregory M. McKee, the Company's President andChief Executive Officer, is scheduled to make a presentation on Thursday,November 1, 2007 at 10:30 am Pacific Time at the BIOCOM Investor Conference2007, which is taking place at the San Diego Marriott Del Mar Hotel.

Gregory McKee will provide an overview of the Company and will discuss theCompany's progress with its investigational therapeutic vaccine, HspE7 forhuman papillomavirus (HPV)-related diseases, and also the Company's businessstrategy. An audio webcast of Nventa's presentation, with an accompanyingslide presentation, will be available onhttp://events.powerstream.net/002/00436/20071101_SDIC/ or on the Company'swebsite at http://www.nventacorp.com on the day of the event. Participantswill need to allow adequate time to download any software necessary for thewebcast.

About Nventa Biopharmaceuticals Corporation:

Nventa is developing innovative therapeutics for the treatment of viralinfections and cancer, with a focus on diseases caused by the humanpapillomavirus (HPV). The corporation is publicly traded on the Toronto StockExchange under the symbol NVN.

For more information about Nventa Biopharmaceuticals Corporation, pleasevisit the Company's website located at http://www.nventacorp.com.

SOURCE Nventa Biopharmaceuticals Corporation

Latest Press Release on General News

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...

Dr. Andres Bustillo Responds to Miami's Growing Interest in Facelift Procedures

In response to the growing demand for facelifts in Miami , Dr. Andres Bustillo , a renowned board-certified facial plastic surgeon, is offering advanced and time-proven techniques in f...

Deepening the Partnership: Dawn Health Introduces Ekiva for Enhanced Disease Management of Paroxysmal Nocturnal Hemoglobinuria (PNH)

COPENHAGEN, Denmark , April 8, 2024 /PRNewswire/ -- Building upon their partnership announced last year, digital health leader Dawn Health and global pharmaceutical company Nov...